Latest filing published 02 Dec 2009 for GENE LOGIC INC, €825.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark J. Gabrielson: trading record in brief
All filings by Mark J. Gabrielson on record concern Gene Logic Inc. We count 7 filings; the first trade dates from 28 November 2007 and the latest from 30 November 2009.
No open-market sale appears; the market trades are 7 purchases worth €10k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2009 to date brings 6 purchases and no sales.
A typical purchase (the median) is worth €834.
Most recently, on 2 December 2009, the filings show an open-market purchase worth €825 in Gene Logic Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark J. Gabrielson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$0.62Common StockSEC:0001209191-09-054996:0Canonical exit: 28 Feb 2010 (T+90)
- 2,000 shares@ US$0.62Common StockSEC:0001209191-09-053957:0Canonical exit: 15 Feb 2010 (T+90)
- 1,980 shares@ US$0.64Common StockSEC:0001209191-09-053957:1Canonical exit: 16 Feb 2010 (T+90)
- 20 shares@ US$0.62Common StockSEC:0001209191-09-053957:2Canonical exit: 16 Feb 2010 (T+90)
- 2,000 shares@ US$0.58Common StockSEC:0001209191-09-042437:0Canonical exit: 25 Nov 2009 (T+90)
- 2,000 shares@ US$0.595Common StockSEC:0001209191-09-041232:0Canonical exit: 16 Nov 2009 (T+90)
- 10,000 shares@ US$0.9374Common StockSEC:0001209191-07-066642:0Canonical exit: 26 Feb 2008 (T+90)
7 of 7 declarations